載入...
Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
BACKGROUND: In type 2 diabetes mellitus (T2DM) there is a progressive loss of β-cell function. One new approach yielding promising results is the use of the orally active dipeptidyl peptidase-4 (DPP-4) inhibitors. However, every new compound for T2DM has to prove long-term safety especially on cardi...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2597770/ https://ncbi.nlm.nih.gov/pubmed/19065993 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|